Effect of Infant Formulas Containing a New Fat Blend or the New Fat Blend Plus Fiber in Healthy Term Infants (9055A1-2000)

March 10, 2026 updated by: Société des Produits Nestlé (SPN)

Effect of an Infant Formula With High 2-Palmitic Vegetable Oil or an Identical Formula Supplemented With Oligofructose on Stool Composition and Stool Characteristics in Healthy Term Infants in Taiwan

  • The primary objective of the study was to compare stool composition (stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents) of infants randomized to receive either standard formula, or 1 of 2 innovative formulas containing a new fat blend or the new fat blend plus fiber.
  • The secondary objectives were to evaluate among the feeding groups, stool characteristics (stool consistency and frequency), GI tolerance assessed by the Infant Gastrointestinal Symptom Questionnaire (IGSQ), and urinary markers (F2-isoprostanes and 8-hydroxy-2'-deoxyguanosine [8-OHdG], and urine osmolality and specific gravity).
  • The primary safety objective was to describe the frequency of adverse events (AEs) among the formula-fed (FF) groups.
  • The secondary safety objective was to describe anthropometric measures (weight, length, and head circumference) among the feeding groups.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

220

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hsinchu, Taiwan
        • Mackay Memorial Hospital - Hsinchu Branch
      • Taipei, Taiwan
        • Mackay Memorial Hospital
      • Taipei, Taiwan
        • Chang Gung Medical Foundation, Taipei Branch
    • Tao-Yuan County
      • Linkou District, Tao-Yuan County, Taiwan
        • Chang Gung Medical Foundation - Linkou Branch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 weeks to 1 month (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy, term (no less than 37 weeks and no greater than 42 weeks) singleton infants; between 25 days to 45 days post natal age (date of birth = Day 0) and weight for age ≥3rd and ≤97th percentiles according to Taiwan growth charts at the time of study entry.
  • Human milk fed infants were exclusively consuming and tolerating HM and the mother must have made the decision to continue to exclusively breastfeed.
  • Formula-fed infants were exclusively consuming and tolerating a cow's milk infant formula and parents/LAR must have previously made the decision to continue to exclusively formula feed.

Exclusion Criteria:

  • Infants receiving any amount of supplemental HM with infant formula feeding or vice versa
  • Family history of siblings with documented cow's milk protein intolerance/allergy
  • Major congenital malformations, suspected or documented systemic or congenital infections, evidence systemic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Control
Standard infant formula
Infant formula
Experimental: Experimental 1
Standard infant formula containing a new fat blend
Infant formula
Experimental: Experimental 2
Standard infant formula containing a new fat blend and fiber
Infant formula
No Intervention: Human Milk (HM)
Non-randomized Human Milk group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stool Composition
Time Frame: Day 28
Stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents
Day 28

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stool Consistency determined using a 3-day stool diary
Time Frame: Days 14 and 28
Stool consistency data is collected using a 3-day stool diary completed by parents just prior to the Day 14 and Day 28 clinic visits. Average stool consistency scores are recorded on a validated 5-point scale (1 = Watery, 2 = Runny, 3 = Mushy Soft, 4 = Formed, 5 = Hard).
Days 14 and 28
Stool frequency determined using a 3-day stool diary
Time Frame: Day 14 and 28
Stool frequency data is collected using a 3-day stool diary completed by parents just prior to the Day 14 and Day 28 clinic visits. The average number of stools per day is determined for each consecutive 3-day period.
Day 14 and 28
GI Tolerance
Time Frame: Baseline, Day 14 and Day 28
GI tolerance assessed by the Infant Gastrointestinal Symptom Questionnaire (IGSQ)
Baseline, Day 14 and Day 28
Incidence of adverse events
Time Frame: From ICF signing until 14 days after last study feeding
From ICF signing until 14 days after last study feeding
Urine osmolality
Time Frame: Baseline and Day 28
Measure of hydration status
Baseline and Day 28
Urine pH
Time Frame: Baseline and Day 28
Measure of hydration status
Baseline and Day 28
Anthropometric measurements
Time Frame: Baseline, Day 14 and Day 28
The anthropometry measurements will be determined by feeding group and by study visit.
Baseline, Day 14 and Day 28
Anthropometric measurements (z-scores)
Time Frame: Baseline, Day 14 and Day 28
The z-scores will be determined by feeding group and by study visit.
Baseline, Day 14 and Day 28

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

December 1, 2011

Study Completion (Actual)

December 1, 2011

Study Registration Dates

First Submitted

December 23, 2013

First Submitted That Met QC Criteria

January 7, 2014

First Posted (Estimated)

January 9, 2014

Study Record Updates

Last Update Posted (Actual)

March 13, 2026

Last Update Submitted That Met QC Criteria

March 10, 2026

Last Verified

March 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bottle Feeding

Clinical Trials on Infant formula

Subscribe